MORAb-066
- Generic Name
- MORAb-066
- Drug Type
- Biotech
- Background
MORAb-066 is a humanized antibody directed against tissue factor (TF). It is being investigated in pancreatic cancer.
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
Phase 1
Completed
- Conditions
- AdenocarcinomaColorectal CancerCarcinoma, Non-Small-Cell LungBreast CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Morphotek
- Target Recruit Count
- 27
- Registration Number
- NCT01761240
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath